About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Remission in Adults With Severe Asthma in Thailand | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07328035

Remission in Adults With Severe Asthma in Thailand

The goal of this observational study is to determine the prevalence of remission among adults with severe asthma, as well as the factors associated with remission in Thailand. The main question the s...

Lead sponsor: Thammasat University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Narongkorn Saiphoklang, MD

CONTACT

+6629269794 M_narongkorn@hotmail.com

Pacharaporn Tangsathapornpong, MD

CONTACT

+6629269701 pacharaporn.kaimook@gmail.com

Sponsors

Lead Sponsor

Thammasat University

This study is a cross-sectional study. Thai patients aged 18 years or older with severe asthma are included in the study. Participants will complete two questionnaires about asthma control: the Global Initiative for Asthma (GINA) and the Asthma Control Test (ACT), and will perform spirometry, a fractional exhaled nitric oxide (FeNO) test, and blood eosinophil counts (BEC).

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•severe asthma
•age 18 years or older

Exclusion Criteria

•inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test

Related studies

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department

NCT05691218 · Moderate Asthma Exacerbation, Severe Asthma Exacerbation

Swiss Severe Asthma Register

NCT03984253 · Severe Asthma

Exploring the Lived Experience of Young Adults With Severe Asthma

NCT06681545 · Asthma, Severe Asthma, and more

RECRUITINGPhase 4

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

NCT06385236 · Moderate to Severe Asthma

Enrolling By InvitationPhase 4

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

NCT07343661 · EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 13, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment230

Start dateJan 2026

Last updatedJan 13, 2026

Condition

Severe Asthma Asthma Control Level

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions